Contrast Sensitivity Changes in Center Involving Diabetic Macular Edema Treated with Aflibercept

References

• Das A, McGuire PG, Rangasamy S. Diabetic macular edema: pathophysiology and novel therapeutic targets. Ophthalmology. 2015;122(7):1375–1394. doi:10.1016/j.ophtha.2015.03.024
   PubMed Web of Science ®Google Scholar
• Pelli DG, Robson JG, Wilkins AJ. The design of a new letter chart for measuring contrast sensitivity. Clin Vis Sci. 1988;2:187–99.37.
   Google Scholar
• Wells J, Glassman A, Ayala AR, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema two-year results forma comparative effectiveness randomized trial. Ophthalmology. 2016;123:1351–1359. doi:10.1016/j.ophtha.2016.02.022
   PubMed Web of Science ®Google Scholar
• Wells J, Glassman A, Ayala A, et al.; for the he Diabetic Retinopathy Clinical Research Network. Aflibercept, bevacizumab or ranibizumab for diabetic macular edema. N Engl J Med. 2015;372:1193–1203.
   PubMed Web of Science ®Google Scholar
• Aiello LP, Beck RW, Bressler NM, et al. Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema. Ophthalmology. 2011;118(12):5–14. doi:10.1016/j.ophtha.2011.09.058
   Web of Science ®Google Scholar
• Fatehi N, Nowroozizadeh S, Henry S, Coleman AL, Caprioli J, Nouri-Mahdavi K. Association of structural and functional measures with contrast sensitivity in glaucoma. Am J Ophthalmol. 2017;178:129–139.
   Web of Science ®Google Scholar
• Katz G, Levkovitch-Verbin H, Treister G, Belkin M, Ilany J, Polat U. Mesopic foveal contrast sensitivity is impaired in diabetic patients without retinopathy. Graefes Arch Clin Exp Ophthalmol. 2010;248(12):1699–1703. doi:10.1007/s00417-010-1413-y
   Web of Science ®Google Scholar
• Sokol S, Moskowitz A, Skarf B, Evans R, Molitch M, Senior B. Contrast sensitivity in diabetics with and without background retinopathy. Arch Ophthalmol. 1985;103(1):51–54. doi:10.1001/archopht.1985.01050010055018
   PubMedGoogle Scholar
• Falsini B, Porciatti V, Scalia G, et al. Steady-state pattern electroretinogram in insulin dependent diabetics with no or minimal retinopathy. Doc Ophthalmol. 1989;73(2):193–200. doi:10.1007/BF00155037
   Web of Science ®Google Scholar
• Greenstein V, Sarter B, Hood D, Noble K, Carr R. Hue discrimination and cone pathway sensitivity in early diabetic retinopathy. Invest Ophthalmol Vis Sci. 1990;31:1008–1014.
   Web of Science ®Google Scholar
• Gruber N, Mosimann UP, Muri RM, Nef T. Vision and night driving abilities of the elderly. Traffic Inj Prev. 2013;14(5):477–485. doi:10.1080/15389588.2012.727510
   PubMed Web of Science ®Google Scholar
• Nixon D, Flinn N. Visual function for driving in diabetic macular edema and retinal vein occlusion post-stabilization with anti-vascular endothelial growth factor. Clin Ophthalmol. 2021;15:1659–1666. doi:10.2147/OPTH.S304229
   Web of Science ®Google Scholar
• Elliott DB, Bullimore MA, Bailey IL. Improving the reliability of the Pelli-Robson contrast sensitivity test. Clin Vis Sci. 1991;6:471–475.
   Google Scholar
• Griffin A, Cheng H, Robson J. Measuring contrast sensitivity using CambBlobs2 disposable paper charts in normal subjects. Invest Ophthalmol Vis Sci. 2017;58(8):4231.
   Web of Science ®Google Scholar
• Robson J, Raman R, Jaisankar D, Sapkota RP, Pardhan S. Contrast sensitivity measured with illiterate single use printed paper charts to assess the severity of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2017;58(8):4698.
   Web of Science ®Google Scholar
• Korobelnik J, Do D, Schmidt-Erfurth U, et al. Intravitreal aflibercept for diabetic macular edema. Ophthalmology. 2014;121(11):2247–2254. doi:10.1016/j.ophtha.2014.05.006
   PubMed Web of Science ®Google Scholar
• Nieves-Moreno M, Martínez-de-la-casa JM, Cifuentes-Canorea P, et al. Normative database for separate inner retinal layers thickness using spectral domain optical coherence tomography in Caucasian population. PLoS One. 2017;12(7):e0180450. doi:10.1371/journal.pone.0180450
   Web of Science ®Google Scholar
• Baker CW, Glassman AR, Beaulieu WT, for the DRCR Retina Network, et al. Effect of initial management with aflibercept vs laser photocoagulation vs. observation on vision loss among patients with diabetic macular edema involving the center of the macula and good visual acuity. A randomized clinical trial. JAMA. 321;2019:1880–1894. doi:10.1001/jama.2019.5790
   PubMed Web of Science ®Google Scholar
• Nixon DR, Flinn NA. Evaluation of contrast sensitivity and other visual function outcomes in diabetic macular edema patients following treatment switch to aflibercept from ranibizumab. Clin Ophthalmol. 2018;12:191–197. doi:10.2147/OPTH.S158268
   Web of Science ®Google Scholar
• Grassi M. What is just the right amount of anti-vascular endothelial growth factor treatment for diabetic macular edema?. JAMA Opthal. 2021;139:381–382.
   Web of Science ®Google Scholar
• Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol. 1985;103:1796–1806. doi:10.1001/archopht.1985.01050120030015
   PubMed Web of Science ®Google Scholar
• West SK, Rubin GS, Bowman AT, Munoz B, Bandeen-Roche K, Turano K. How does visual impairment affect performance on tasks of everyday life? The SEE project. Arch Ophthalmol. 2002;120(6):774–780. doi:10.1001/archopht.120.6.774
   PubMed Web of Science ®Google Scholar
• Rubin GS, Bandeen-Roche K, Huang GH, et al. The association of multiple visual impairments with self-reported visual disability: SEE project. Invest Ophthalmol Vis Sci. 2001;42:64–72.
   PubMed Web of Science ®Google Scholar
• Owsley C, Sekuler R, Siemsen D. Contrast sensitivity throughout adulthood. Vision Res. 1983;23(7):689–699. doi:10.1016/0042-6989(83)90210-9
   PubMed Web of Science ®Google Scholar
• Swain T, McGwin G Jr, JM Wood, et al. Naturalistic driving techniques and associated visual risk factors with at-fault crashes and near crashes by older drivers with vision impairment. JAMA Ophthalmol. 2021. doi:10.1001/jamaophthalmol.2021.0862
   Web of Science ®Google Scholar
• Simo R, Stitt A, Gardner T. Neurodegeneration in diabetic retinopathy: does it really matter? Diabetologia. 2018;61(9):1902–1912. doi:10.1007/s00125-018-4692-1
   PubMed Web of Science ®Google Scholar
• Hegazy AI, Zedan RH, Macky TA, Esmat SM. Retinal ganglion cell complex changes using spectral domain optical coherence tomography in diabetic patients without retinopathy. Int J Ophthalmol. 2017;10(3):427. doi:10.18240/ijo.2017.03.16
   Web of Science ®Google Scholar
• George R, Hemamalini A, Baskaran M, Ramesh SV, Raju P, Vijaya L. The Chennai glaucoma study: prevalence and risk factors for glaucoma in cataract operated eyes in urban Chennai Indian. J Ophthalmol. 2010;58(3):243–245.
   Web of Science ®Google Scholar